Small interfering RNA inhibition of andes virus replication

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Chiang, Cheng Feng ^a   Albariňo, Cesar G ^a   Lo, Michael K ^a   Spiropoulou, Christina F ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; VIRUS RNA;

ANDES VIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE TARGETING; HANTAVIRUS; HANTAVIRUS INFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHLOROCEBUS AETHIOPS; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; HANTAVIRUS PULMONARY SYNDROME; LUNG; PATHOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE; VERO CELL LINE; VIROLOGY;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; ENDOTHELIAL CELLS; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; LUNG; PRIMARY CELL CULTURE; RNA, SMALL INTERFERING; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION;

EID: 84903388717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099764     Document Type: Article

References (37)

1. Wells RM, Young J, Williams RJ, Armstrong LR, Busico K, et al. (1997) Hantavirus transmission in the United States. Emerging Infectious Diseases 3: 361-365. (Pubitemid 127431698)
2. Doyle TJ, Bryan RT, Peters CJ (1998) Viral hemorrhagic fevers and hantavirus infections in the Americas. Infectious Disease Clinics of North America 12: 95-110. (Pubitemid 28072502)
3. Chaparro J, Vega J, Terry W, Vera JL, Barra B, et al. (1998) Assessment of person-to-person transmission of hantavirus pulmonary syndrome in a Chilean hospital setting. Journal of Hospital Infection 40: 281-285. (Pubitemid 28552395)
4. Ferres M, Vial P, Marco C, Yanez L, Godoy P, et al. (2007) Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile. Journal of Infectious Diseases 195: 1563-1571. (Pubitemid 46799213)
5. Schmaljohn CS, Nichol ST (2007) Bunyaviridae. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 1741-1789.
6. Enria DA, Briggiler AM, Pini N, Levis S (2001) Clinical manifestations of New World hantaviruses. Current Topics in Microbiology and Immunology 256: 117-134.
7. Terajima M, Hendershot JD, 3rd, Kariwa H, Koster FT, Hjelle B, et al. (1999) High levels of viremia in patients with the Hantavirus pulmonary syndrome. Journal of Infectious Diseases 180: 2030-2034.
8. Jonsson CB, Hooper J, Mertz G (2008) Treatment of hantavirus pulmonary syndrome. Antiviral Research 78: 162-169.
9. Xiao R, Yang S, Koster F, Ye C, Stidley C, et al. (2006) Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. Journal of Infectious Diseases 194: 1403-1409. (Pubitemid 44706509)
10. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, et al. (2004) Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clinical Infectious Diseases 39: 1307-1313. (Pubitemid 39458516)
11. Umbach JL, Cullen BR (2009) The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev 23: 1151-1164.
12. Jeang KT (2012) RNAi in the regulation of mammalian viral infections. BMC Biol 10: 58.
13. Doi N, Zenno S, Ueda R, Ohki-Hamazaki H, Ui-Tei K, et al. (2003) Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors. Current Biology 13: 41-46. (Pubitemid 36080621)
14. Flusin O, Vigne S, Peyrefitte CN, Bouloy M, Crance JM, et al. (2011) Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin. Virol J 8: 249.
15. Muller S, Gunther S (2007) Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus. Antimicrobial Agents and Chemotherapy 51: 2215-2218. (Pubitemid 46903121)
16. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, et al. (2002) siRNA-directed inhibition of HIV-1 infection. Nat Med 8: 681-686. (Pubitemid 34778720)
17. Gitlin L, Karelsky S, Andino R (2002) Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418: 430-434. (Pubitemid 34826844)
18. Dykxhoorn DM, Lieberman J (2006) Silencing viral infection. PLoS Med 3: e242.
19. Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, et al. (2010) Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 375: 1896-1905.
20. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, et al. (2010) A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A 107: 8800-8805.
21. Zhou J, Rossi JJ (2011) Progress in RNAi-based antiviral therapeutics. Methods Mol Biol 721: 67-75.
22. Spiropoulou CF, Albarino CG, Ksiazek TG, Rollin PE (2007) Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81: 2769-2776. (Pubitemid 46447041)
23. Aljofan M, Sganga ML, Lo MK, Rootes CL, Porotto M, et al. (2009) Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro. Virol J 6: 187.
24. Levin A, Kutznetova L, Kahana R, Rubinstein-Guini M, Stram Y (2006) Highly effective inhibition of Akabane virus replication by siRNA genes. Virus Res 120: 121-127. (Pubitemid 43947307)
25. Soldan SS, Plassmeyer ML, Matukonis MK, Gonzalez-Scarano F (2005) La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. J Virol 79: 234-244. (Pubitemid 39648379)
26. Billecocq A, Vazeille-Falcoz M, Rodhain F, Bouloy M (2000) Pathogen-specific resistance to Rift Valley fever virus infection is induced in mosquito cells by expression of the recombinant nucleoprotein but not NSs non-structural protein sequences. J Gen Virol 81: 2161-2166.
27. Hutchinson KL, Peters CJ, Nichol ST (1996) Sin Nombre virus mRNA synthesis. Virology 224: 139-149. (Pubitemid 26358109)
28. Kariwa H, Tanabe H, Mizutani T, Kon Y, Lokugamage K, et al. (2003) Synthesis of Seoul virus RNA and structural proteins in cultured cells. Arch Virol 148: 1671-1685. (Pubitemid 37144172)
29. Mir MA, Panganiban AT (2004) Trimeric hantavirus nucleocapsid protein binds specifically to the viral RNA panhandle. J Virol 78: 8281-8288. (Pubitemid 38944312)
30. Alminaite A, Halttunen V, Kumar V, Vaheri A, Holm L, et al. (2006) Oligomerization of hantavirus nucleocapsid protein: analysis of the N-terminal coiled-coil domain. J Virol 80: 9073-9081. (Pubitemid 44359981)
31. Severson WE, Xu X, Jonsson CB (2001) cis-Acting signals in encapsidation of Hantaan virus S-segment viral genomic RNA by its N protein. J Virol 75: 2646-2652. (Pubitemid 32185027)
32. Mir MA, Panganiban AT (2008) A protein that replaces the entire cellular eIF4F complex. EMBO J 27: 3129-3139.
33. Schmaljohn CS, Nichol ST (2001) Hantaviruses. Berlin; New York: Springer. vii, 196 p. p.
34. Powers AM, Kamrud KI, Olson KE, Higgs S, Carlson JO, et al. (1996) Molecularly engineered resistance to California serogroup virus replication in mosquito cells and mosquitoes. Proc Natl Acad Sci U S A 93: 4187-4191. (Pubitemid 26144260)
35. Borges AA, Campos GM, Moreli ML, Souza RL, Aquino VH, et al. (2006) Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect 8: 2324-2330. (Pubitemid 44311596)
36. Spiropoulou CF, Goldsmith CS, Shoemaker TR, Peters CJ, Compans RW (2003) Sin Nombre virus glycoprotein trafficking. Virology 308: 48-63. (Pubitemid 36428964)
37. McNulty S, Flint M, Nichol ST, Spiropoulou CF (2013) Host mTORC1 signaling regulates Andes virus replication. J Virol 87: 912-922.